A1BG | Alpha-1-B glycoprotein | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
AAMP | Angio-associated, migratory cell protein | Plasma proteins
| | | | | Expressed in all |
AARS | Alanyl-tRNA synthetase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA3 | ATP-binding cassette, sub-family A (ABC1), member 3 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABHD14B | Abhydrolase domain containing 14B | Plasma proteins
| | | | | Expressed in all |
ACAA1 | Acetyl-CoA acyltransferase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACAA2 | Acetyl-CoA acyltransferase 2 | Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ACADS | Acyl-CoA dehydrogenase, C-2 to C-3 short chain | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACAP2 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | Plasma proteins
| | | | | Expressed in all |
ACAT1 | Acetyl-CoA acetyltransferase 1 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACAT2 | Acetyl-CoA acetyltransferase 2 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACBD3 | Acyl-CoA binding domain containing 3 | Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACIN1 | Apoptotic chromatin condensation inducer 1 | Plasma proteins Transporters
| | | | | Expressed in all |
ACLY | ATP citrate lyase | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |
ACO1 | Aconitase 1, soluble | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |
ACO2 | Aconitase 2, mitochondrial | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | | | Expressed in all |
ACOT8 | Acyl-CoA thioesterase 8 | Enzymes Plasma proteins
| | | | | Expressed in all |
ACP1 | Acid phosphatase 1, soluble | Enzymes Plasma proteins
| | | | | Expressed in all |
ACP5 | Acid phosphatase 5, tartrate resistant | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Expressed in all |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACTA1 | Actin, alpha 1, skeletal muscle | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Tissue enriched |
ACTA2 | Actin, alpha 2, smooth muscle, aorta | Cytoskeleton related proteins Disease related genes Plasma proteins
| | | | | Expressed in all |
ACTC1 | Actin, alpha, cardiac muscle 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |
ACTL6A | Actin-like 6A | Plasma proteins
| | | | | Expressed in all |
ACTN4 | Actinin, alpha 4 | Disease related genes Plasma proteins
| | | | | Expressed in all |
ACTR1A | ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | Plasma proteins
| | | | | Expressed in all |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMTS9 | ADAM metallopeptidase with thrombospondin type 1 motif, 9 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
ADAR | Adenosine deaminase, RNA-specific | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
ADD1 | Adducin 1 (alpha) | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
ADH1A | Alcohol dehydrogenase 1A (class I), alpha polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADH1B | Alcohol dehydrogenase 1B (class I), beta polypeptide | Enzymes FDA approved drug targets Plasma proteins
| | | | | Group enriched |
ADH4 | Alcohol dehydrogenase 4 (class II), pi polypeptide | Enzymes Plasma proteins
| | | | | Tissue enriched |
ADH5 | Alcohol dehydrogenase 5 (class III), chi polypeptide | Enzymes Plasma proteins
| | | | | Expressed in all |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADRBK1 | Adrenergic, beta, receptor kinase 1 | Enzymes Plasma proteins
| | | | | Expressed in all |